Skip to main content

Table 1 Characteristics and clinical presentation for six dogs exposed to anticoagulant rodenticides (ARs)

From: Determination of anticoagulant rodenticides in faeces of exposed dogs and in a healthy dog population

Case number

Age

(years)

Weight

(kg)

Clinical signs

Coagulation status

Detected ARs

Treatment

Duration of detectable AR concentrations after ingestion

Blood

Faeces

1

0.5

7

L, PMM, TP, DP, T

Prolonged

Brodifacoum

Vitamin K1, oxygen, fluids

7

At least 969a

2

2

6

L, PMM, TP, DP, T, I, LT

Prolonged

Brodifacoum

Blood transfusion, Vitamin K1, oxygen, fluids

53b

At least 894b

3

8

16

None

Normal

Brodifacoum

Emeticum, activated charcoal

9

At least 700

4

0.6

11

None

Normal

Bromadiolone

Emeticum, activated charcoal

n.d.

151

5

0.8

22

None

Normal

Bromadiolone

Emeticum, activated charcoal, fluids

n.d.

3

6

9.5

26

None

Prolonged (day 3)

Difenacoum

Emeticum, Vitamin K1

9

At least 653

  1. n.d. Not detected, L lethargy, PMM pale mucous membranes, TP tachypnea, DP dyspnea, T tachycardia, I inappetence, LT low temperature
  2. aProbable new exposure detected day 1032
  3. bAfter first visit, day of ingestion unknown